Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer
出版年份 2014 全文链接
标题
Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 110, Issue 7, Pages 1793-1800
出版商
Springer Nature
发表日期
2014-02-19
DOI
10.1038/bjc.2014.87
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor
- (2013) Y Wang et al. BRITISH JOURNAL OF CANCER
- The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
- (2013) Mikael Johansson et al. NEURO-ONCOLOGY
- LRIG1 modulates aggressiveness of head and neck cancers by regulating EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling
- (2013) J J-C Sheu et al. ONCOGENE
- Absent/weak CD44 intensity and positive human papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma indicates a very high survival
- (2013) Anders Näsman et al. Cancer Medicine
- The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor
- (2012) Anne E. Powell et al. CELL
- Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity
- (2011) Xuping Wu et al. ACTA ONCOLOGICA
- Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates with Longer Relapse-Free Survival in ER -Positive Breast Cancer
- (2011) S. R. Krig et al. MOLECULAR CANCER RESEARCH
- LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix
- (2010) Håkan Hedman et al. ACTA ONCOLOGICA
- Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1
- (2010) Wei Yi et al. EXPERIMENTAL CELL RESEARCH
- Human papillomavirus and survival in patients with base of tongue cancer
- (2010) Per Attner et al. INTERNATIONAL JOURNAL OF CANCER
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer
- (2010) Marcus Thomasson et al. INTERNATIONAL JOURNAL OF CANCER
- Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?
- (2009) Anders Näsman et al. INTERNATIONAL JOURNAL OF CANCER
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
- (2009) James A Bonner et al. LANCET ONCOLOGY
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
- (2009) Jean-Pierre Pignon et al. RADIOTHERAPY AND ONCOLOGY
- Lrig1 Is an Endogenous Inhibitor of Ret Receptor Tyrosine Kinase Activation, Downstream Signaling, and Biological Responses to GDNF
- (2008) F. Ledda et al. JOURNAL OF NEUROSCIENCE
- LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII
- (2008) M A Stutz et al. ONCOGENE
- LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking
- (2007) A.K. LINDSTRÖM et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Redistribution of LRIG Proteins in Psoriasis
- (2007) Terese Karlsson et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now